, Volume 12, Issue 6, pp 352-354
Date: 01 Sep 2010

The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access